azomycin has been researched along with Fibrosarcoma in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (58.70) | 18.7374 |
1990's | 7 (15.22) | 18.2507 |
2000's | 11 (23.91) | 29.6817 |
2010's | 1 (2.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denekamp, J; Minchinton, AI; Stratford, MR; Williams, MV | 1 |
Banerjee, S; Mallia, MB; Mathur, A; Sarma, HD; Subramanian, S | 1 |
Busch, TM; Durduran, T; Wang, HW; Wang, KK; Wileyto, EP; Xing, X; Yodh, A; Yu, G; Zhu, TC | 1 |
Busch, TM; Del Piero, F; Emanuele, MJ; Glatstein, E; Koch, CJ; Marconato, L; Wileyto, EP | 1 |
Cai, S; Chapman, JD; Chen, Y; Finn, R; Gerweck, L; Humm, J; Larson, S; Ling, C; O'Donoghue, J; Ruan, S; Schneider, R; Wen, B; Zanzonico, P | 1 |
De Bast, M; Gillart, J; Gregoire, V; Labar, D; Leveque, PH; Mahy, P; Marchand, J | 1 |
Braun, RD; Brizel, DM; Cárdenas-Navia, LI; Dewhirst, MW; Secomb, TW; Yu, D | 1 |
De Bast, M; Gillart, J; Grégoire, V; Labar, D; Mahy, P | 1 |
Banerjee, S; Mallia, MB; Sarma, HD; Subramanian, S; Venkatesh, M | 1 |
Busk, M; Bussink, J; Horsman, MR; Jakobsen, S; Keiding, S; Overgaard, J; van der Kogel, AJ | 1 |
Hinchliffe, M; McNally, NJ | 1 |
Denekamp, J; Rojas, A; Stewart, FA | 1 |
Hunter, N; Ito, H; Milas, L | 1 |
Denekamp, J; Rojas, A | 1 |
Meyn, RE; Murray, D | 4 |
Okada, S; Sakamoto, K; Takada, C; Takahashi, M; Yasunaga, T | 1 |
Grdina, DJ; Milas, L; Thames, HD | 1 |
Baer, K; Chapman, JD; Lee, J | 1 |
Dembs, N; Mulcahy, RT | 1 |
Creasey, WA; Thrall, DE | 1 |
De Ronde, J; Martin, WM; McNally, NJ | 1 |
Grdina, DJ; Jovonovich, JA; Sigdestad, CP | 1 |
Tannock, IF | 2 |
Aboagye, EO; Cannell, MB; Griffiths, JR; Judson, IR; Leach, MO; McSheehy, PM; Ojugo, AS; Robinson, SP | 1 |
Busch, TM; Evans, SM; Hahn, SM; Koch, CJ | 1 |
O'Hara, JA; Paulsen, KD; Pogue, BW; Swartz, HM; Wilmot, CM | 1 |
Airley, R; Cowen, RL; Honess, D; Jaffar, M; Patterson, AV; Saunders, M; Stratford, IJ; Telfer, BA; van der Kogel, AJ; Williams, KJ; Wolf, CR | 1 |
Denekamp, J; Flockhart, IR; McNally, NJ; Sheldon, P; Stewart, FA | 1 |
Reddy, EK | 1 |
Bleehen, NM; Owen, LN; White, RA; Workman, P | 1 |
George, KC; Hirst, DG; McNally, NJ | 1 |
Gulyas, S; Mohindra, JK; Varghese, AJ | 1 |
Bubley, G; Coleman, CN; Eder, JP; Frei, E; Herman, TS; Holden, SA; Tanaka, J; Teicher, BA | 1 |
Herman, TS; Holden, SA; Teicher, BA | 1 |
Bubley, G; Coleman, CN; Frei, E; Herman, TS; Shulman, L; Teicher, BA | 1 |
Arundel-Suto, CM; Elliott, WE; Leopold, WR; Sebolt-Leopold, JS; Stier, MA; Suto, MJ; Werbel, LM | 1 |
Herman, TS; Holden, SA; Jones, SM; Pfeffer, MR; Teicher, BA | 1 |
Chapnick, RM; Herman, TS; Kalick, GS; Khandekar, V; Pfeffer, MR; Rabow, A; Teicher, BA | 1 |
Herman, TS; Holden, SA; Jones, SM; Teicher, BA | 1 |
Bleehen, NM; Walton, MI; Workman, P | 1 |
Lee, FY; Workman, P | 1 |
Denekamp, J; Randhawa, VS; Stewart, FA; Stratford, MR | 1 |
46 other study(ies) available for azomycin and Fibrosarcoma
Article | Year |
---|---|
In vivo assessment of basic 2-nitroimidazole radiosensitizers.
Topics: Animals; Dose-Response Relationship, Drug; Female; Fibrosarcoma; Mice; Mice, Inbred Strains; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1982 |
A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: some observations towards possible improvement in in vivo efficacy.
Topics: Animals; Biological Transport; Biomarkers, Tumor; Cell Hypoxia; Fibrosarcoma; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Nitroimidazoles; Organotechnetium Compounds; Radiochemistry; Tissue Distribution | 2014 |
Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
Topics: Animals; Cell Hypoxia; Dihematoporphyrin Ether; Fibrosarcoma; Light; Mice; Mice, Inbred C3H; Neoplasms, Radiation-Induced; Nitroimidazoles; Photochemotherapy; Photosensitizing Agents | 2009 |
Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Dihematoporphyrin Ether; Fibrosarcoma; Immunohistochemistry; Mice; Mice, Inbred C3H; Microscopy, Fluorescence; Neoplasms, Radiation-Induced; Nitroimidazoles; Oxygen; Oxygen Consumption; Photochemotherapy | 2002 |
Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Female; Fibrosarcoma; Mammary Neoplasms, Animal; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Misonidazole; Monosaccharides; Nitroimidazoles; Organ Specificity; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3.
Topics: Animals; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Drug Evaluation, Preclinical; Fibrosarcoma; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Nitroimidazoles; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2004 |
Tumor-dependent kinetics of partial pressure of oxygen fluctuations during air and oxygen breathing.
Topics: Air; Animals; Cell Hypoxia; Female; Fibrosarcoma; Fourier Analysis; Glioma; Immunohistochemistry; Nitroimidazoles; Oxygen; Partial Pressure; Rats; Rats, Inbred F344 | 2004 |
Detection of tumour hypoxia: comparison between EF5 adducts and [18F]EF3 uptake on an individual mouse tumour basis.
Topics: Animals; Cell Hypoxia; Drug Evaluation, Preclinical; Etanidazole; Fibrosarcoma; Fluorescent Antibody Technique; Hydrocarbons, Fluorinated; Male; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Nitroimidazoles; Organ Specificity; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2006 |
Evaluation of 99mTc(CO)3 complex of 2-methyl-5-nitroimidazole as an agent for targeting tumor hypoxia.
Topics: Animals; Drug Carriers; Drug Stability; Fibrosarcoma; Hypoxia; Ligands; Mice; Neoplasms; Nitroimidazoles; Organotechnetium Compounds; Tissue Distribution | 2006 |
Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Fibrosarcoma; Fluorine Radioisotopes; Immunocompromised Host; Immunohistochemistry; Mice; Mice, Inbred C3H; Mice, Nude; Microscopy, Fluorescence; Nitroimidazoles; Oxygen; Polarography; Positron-Emission Tomography; Radiation-Sensitizing Agents; Transplantation, Heterologous | 2008 |
A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Etanidazole; Fibrosarcoma; Melphalan; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
Topics: Amifostine; Animals; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Fibrosarcoma; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Radiation Tolerance; Sarcoma, Experimental | 1983 |
Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Topics: Amifostine; Animals; Cyclophosphamide; Drug Interactions; Drug Therapy, Combination; Extremities; Female; Fibrosarcoma; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Time Factors | 1983 |
Time dependence of interaction of misonidazole and WR-2721.
Topics: Amifostine; Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Fibrosarcoma; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Organothiophosphorus Compounds; Sarcoma, Experimental; Time Factors | 1983 |
Effect of misonidazole pretreatment on nitrogen mustard-induced DNA cross-linking in mouse tissues in vivo.
Topics: Animals; Cross-Linking Reagents; DNA; Drug Synergism; Fibrosarcoma; Jejunum; Kidney; Liver; Mechlorethamine; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Spleen | 1984 |
[Effect of even or uneven dose fractionation regime on murine squamous cell carcinoma with combined use of misonidazole].
Topics: Animals; Carcinoma, Squamous Cell; Combined Modality Therapy; Fibrosarcoma; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles; Radiotherapy Dosage | 1983 |
Enhancement of the DNA cross-linking activity of nitrogen mustard by misonidazole and diethyl maleate in a mouse fibrosarcoma tumor in vivo.
Topics: Animals; DNA, Neoplasm; Drug Administration Schedule; Fibrosarcoma; Kinetics; Maleates; Mechlorethamine; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles | 1984 |
Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Radiation; Female; Fibrosarcoma; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation Tolerance; Sarcoma, Experimental; Tumor Stem Cell Assay | 1984 |
Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
Topics: Animals; Cross-Linking Reagents; DNA; DNA Repair; DNA, Neoplasm; Fibrosarcoma; Glutathione; Jejunum; Maleates; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Spleen | 1983 |
Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
Topics: Anaerobiosis; Animals; Binding, Competitive; Cell Line; Cricetinae; Cricetulus; Fibrosarcoma; Kidney; Kinetics; Mice; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Temperature | 1983 |
Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
Topics: Animals; Carmustine; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Fibrosarcoma; Mice; Misonidazole; Nitroimidazoles; Time Factors | 1983 |
Pharmacokinetic and anti-tumor studies with the radiosensitizer misonidazole in dogs with spontaneous fibrosarcomas.
Topics: Animals; Dog Diseases; Dogs; Fibrosarcoma; Mandibular Neoplasms; Maxillary Neoplasms; Misonidazole; Mouth Neoplasms; Nitroimidazoles; Palate, Soft | 1982 |
Enhancement of the effect of cytotoxic drugs by radiosensitizers.
Topics: Animals; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Fibrosarcoma; In Vitro Techniques; Melphalan; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Urination | 1981 |
The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Fibrosarcoma; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1980 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
Topics: Animals; Body Weight; Doxorubicin; Drug Therapy, Combination; Fibrosarcoma; Fluorouracil; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Methotrexate; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Topics: Animals; Body Weight; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Fibrosarcoma; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo.
Topics: Animals; Biological Transport; Carbon Dioxide; Fibrosarcoma; Fluorouracil; Hydrogen-Ion Concentration; Hypoxia; Mice; Mice, Inbred C3H; Nitroimidazoles; Nuclear Magnetic Resonance, Biomolecular; Oxygen; Sarcoma, Experimental | 1998 |
Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].
Topics: Animals; Cell Separation; Fibrosarcoma; Flow Cytometry; Mice; Microscopy, Fluorescence; Molecular Probes; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Nitroimidazoles; Oxygen Consumption; Photochemotherapy; Tumor Cells, Cultured | 2000 |
Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based interpretation of pimonidazole hypoxia and eppendorf measurements.
Topics: Animals; Cell Hypoxia; Data Interpretation, Statistical; Diffusion; Female; Fibrosarcoma; Kinetics; Mice; Models, Biological; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Nitroimidazoles; Oxygen; Oxygen Consumption; Partial Pressure; Radiation-Sensitizing Agents; Staining and Labeling | 2001 |
Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours.
Topics: Animals; Combined Modality Therapy; Female; Fibrosarcoma; Genetic Therapy; Genetic Vectors; Humans; Hypoxia; Mice; Mice, Nude; Misonidazole; NADPH-Ferrihemoprotein Reductase; Neoplasm Transplantation; Nitroimidazoles; Prodrugs; Radiation Tolerance; Radiation-Sensitizing Agents; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
Topics: Animals; Female; Fibrosarcoma; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Osteosarcoma; Oxygen; Radiation-Sensitizing Agents; Time Factors; Transplantation, Isogeneic | 1978 |
A comparison of the effects of tumour growth delay of fractionated and single dose irradiation when administered with misonidazole (Ro-07-0582).
Topics: Animals; Fibrosarcoma; Male; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; Rats; Sarcoma, Experimental; Time Factors | 1978 |
The penetration of misonidazole into spontaneous canine tumours.
Topics: Adenocarcinoma; Anesthesia, Intravenous; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Dog Diseases; Dogs; Female; Fibrosarcoma; Half-Life; Lymphoma, Non-Hodgkin; Male; Mammary Glands, Animal; Meningioma; Misonidazole; Neoplasms; Nitroimidazoles; Osteosarcoma; Pentobarbital | 1979 |
Effect of hyperthermia on cytotoxicity of the radiosensitizer Ro-07-0582 in a solid mouse tumour.
Topics: Animals; Cell Survival; Fibrosarcoma; Hot Temperature; Mice; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Time Factors | 1977 |
Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo.
Topics: Animals; Cells, Cultured; Fibrosarcoma; Hypoxia; Nitrogen; Nitroimidazoles; Oxidation-Reduction; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1976 |
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbon Dioxide; Carboplatin; Carmustine; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Etanidazole; Fibrosarcoma; Flow Cytometry; Fluorocarbons; Hydroxyethyl Starch Derivatives; Mammary Neoplasms, Experimental; Melphalan; Mice; Nitroimidazoles; Organoplatinum Compounds; Oxygen; Radiation-Sensitizing Agents; Thiotepa | 1991 |
Effect of pH, oxygenation, and temperature on the cytotoxicity and radiosensitization by etanidazole.
Topics: Animals; Benzimidazoles; Cell Division; Cell Line; Cell Survival; Etanidazole; Fibrosarcoma; Flow Cytometry; Fluorescent Dyes; Hydrogen-Ion Concentration; Hyperthermia, Induced; Hypoxia; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Temperature | 1991 |
Combination of etanidazole with cyclophosphamide and platinum complexes.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Cells; Carboplatin; Cell Survival; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Etanidazole; Fibrosarcoma; Hematopoietic Stem Cells; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Nitroimidazoles; Time Factors | 1991 |
A new class of analogues of the bifunctional radiosensitizer alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines.
Topics: Animals; Aziridines; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; Cricetinae; Fibrosarcoma; Mice; Misonidazole; Molecular Structure; Nitroimidazoles; Oxygen; Pyrans; Radiation-Sensitizing Agents; Structure-Activity Relationship | 1991 |
Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
Topics: Animals; Cell Survival; Cisplatin; Combined Modality Therapy; Drug Therapy, Combination; Etanidazole; Fibrosarcoma; Hyperthermia, Induced; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1990 |
Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
Topics: Animals; Cell Line; Cell Survival; Cisplatin; Etanidazole; Fibrosarcoma; Hydrogen-Ion Concentration; In Vitro Techniques; Mice; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1990 |
Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Drug Combinations; Etanidazole; Fibrosarcoma; Fluorocarbons; Hydroxyethyl Starch Derivatives; Hyperthermia, Induced; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1989 |
Heat-stimulated nitroreductive bioactivation of the 2-nitroimidazole benznidazole in vitro.
Topics: Animals; Fibrosarcoma; Hot Temperature; Kinetics; Male; Mice; Mice, Inbred C3H; Microsomes, Liver; Nitrate Reductase; Nitrate Reductases; Nitroimidazoles | 1987 |
Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU.
Topics: Administration, Oral; Animals; Drug Interactions; Fibrosarcoma; Injections, Intraperitoneal; Lethal Dose 50; Lomustine; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles | 1985 |
Factors influencing the chemosensitization of melphalan by misonidazole.
Topics: Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrosarcoma; Kinetics; Melphalan; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles; Temperature | 1985 |
DNA damage in normal and neoplastic mouse tissues after treatment with misonidazole in vivo.
Topics: Animals; Cell Line; DNA; DNA, Neoplasm; Dose-Response Relationship, Drug; Fibrosarcoma; Hydrogen-Ion Concentration; Kidney; Kinetics; Liver; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Organ Specificity | 1985 |